Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
NCT00465907
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Low accrual
Conditions
Lung Cancer
Interventions
DRUG:
Paclitaxel, Carboplatin and Irinotecan
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins